| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.5 |